Login

Shawn Shirazi, Chief Executive Officer , Theralase Technologies Inc. 00:00:00

Share On Facebook Share On Twitter

Shawn Shirazi, Chief Executive Officer , Theralase Technologies Inc.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Egor Pradeshev, Senior Analyst at Roskill: EV and Lithium Battery Market Trends and Outlook
00:10:00
2019 Fink Investing Conference: Keynote Conversation with Ric Kayne
00:10:00
Innovations at K.EY 2023 as Told by Davide Tinazzi | Davide Tinazzi - CEO of Energy SpA
00:10:00
Blue Sky Uranium's Amarillo Grande Project: Expanding Argentina's Uranium Potential
00:10:00
Mr. CEO Unveils Embraer's New Turboprop with 250+ LOIs | Arjan Meijer - CEO of Embraer
00:10:00
Caliber Mining's Ryan King Discusses Q2 Financials and Hub-and-Spoke Success in Nicaragua
00:10:00
Mission is to bridge the gap in venture capital funding for women|Ayana Parsons,Founding Partner,Fearless Fund
00:10:00
Interactive Session with Aleksander Caban: Carbon Studio's Path to VR Innovation | Aleksander Caban, a board member , Carbon Studio SA.
00:10:00
ESG and Impact Investing: A Masterclass with Latham & Watkins | Sarah E. Fortt - Partner of Latham & Watkins
00:10:00
Jim Cramer interviews Pegasystems CEO Alan Trefler on how clients are leveraging the software firm for customer solutions.
00:10:00
Recent Acquisitions and Future Growth Prospects | Bill Trimble, CEO, Easterly Government Properties Inc
00:10:00
Bennett Goodman to Leave Blackstone, Start Family Office

© 2026 Nehu